{
    "2020-04-26": [
        [
            {
                "time": "",
                "orginal_text": "湖北率先对新冠检测试剂带量采购，六家企业低价中标！试剂集采突破口已显现？",
                "features": {
                    "keywords": [
                        "新冠检测试剂",
                        "带量采购",
                        "低价中标"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "互联网医疗企业助力全民抗疫“下半场”：在线检测",
                "features": {
                    "keywords": [
                        "互联网医疗",
                        "在线检测",
                        "抗疫"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "互联网"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "鹰眼预警：华大基因营收净利变动背离 净现比小于1",
                "features": {
                    "keywords": [
                        "华大基因",
                        "营收净利背离",
                        "净现比"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "华大基因去年净利减三成，今年一季度因新冠检测需求业绩大增",
                "features": {
                    "keywords": [
                        "华大基因",
                        "新冠检测",
                        "业绩增长"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "[东兴医药胡博新团队]华大基因（300676）：新冠病毒检测业绩持续兑现",
                "features": {
                    "keywords": [
                        "华大基因",
                        "新冠病毒检测",
                        "业绩兑现"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "华大基因2019年净利降三成，市值却单月爆增百亿",
                "features": {
                    "keywords": [
                        "华大基因",
                        "净利下降",
                        "市值增长"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "mixed",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "主力抱团医疗消费防御板块 特高压概念暂歇喘息",
                "features": {
                    "keywords": [
                        "医疗消费",
                        "防御板块",
                        "特高压"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "消费",
                        "能源"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}